---
title: "MarketAxess Q2 2026 earnings preview"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295112949.md"
description: "MarketAxess (MKTX) is set to report Q2 2026 earnings on August 7th. Consensus estimates project EPS of $1.97 (-1.5% YoY) and revenue of $219.38M (-0.1% YoY). Historically, the company has beaten EPS estimates 100% of the time and revenue estimates 75% of the time over the past year."
datetime: "2026-08-06T13:31:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295112949.md)
  - [en](https://longbridge.com/en/news/295112949.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295112949.md)
generator: "portal-rs"
---

# MarketAxess Q2 2026 earnings preview

MarketAxess (MKTX) is scheduled to announce Q2 earnings results on Friday, August 7th, before market open. The consensus EPS Estimate is $1.97 (-1.5% Y/Y) and the consensus Revenue Estimate is $219.38M (-0.1% Y/Y). Over the last 1 year, MKTX has beaten EPS estimates 100% of the time and has beaten revenue estimates 75% of the time. Over the last 3 ...

### Related Stocks

- [MKTX.US](https://longbridge.com/en/quote/MKTX.US.md)

## Related News & Research

- [Coinbase Stock And Other Flight To Safety Plays In US Cash Management](https://longbridge.com/en/news/297246069.md)
- [MarketAxess General Counsel Scott Pintoff sells 100 shares worth $16,260](https://longbridge.com/en/news/295445040.md)
- [Intercontinental Exchange Extends $3.9B Revolver, Secures $2B Term Loan as $6.2B Bridge Is Canceled](https://longbridge.com/en/news/296611909.md)
- [Invex to distribute MXN 11.5 million capital repayment on Sept. 2, 2026](https://longbridge.com/en/news/297023868.md)
- [NewAmsterdam Pharma to present Phase 3 obicetrapib trial data at ESC Congress 2026](https://longbridge.com/en/news/297041595.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**